ERAS

Erasca (ERAS)

About Erasca (ERAS)

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.

Details

Daily high

$10.54

Daily low

$9.94

Price at open

$10.47

52 Week High

$24.28

52 Week Low

$1.06

Market cap

3.1B

Dividend yield

0.00%

Volume

3.1M

Avg. volume

10.6M

P/E ratio

-23.04

Erasca News